🔎 Trials Near Me

ホーム › 膵臓がん › アラバマ州

アラバマ州における膵臓がんの臨床試験

アラバマ州内の拠点で、膵臓がんに関する11件の研究が参加者を募集しています。

アラバマ州内の都市

公式研究テキスト(英語)

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  • Clearview Cancer Institute, Huntsville
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/05更新 · NCT07562152

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06760819

DESTINY-PANTUMOUR04

  • Research Site, Birmingham
被験者募集中観察研究
18歳〜130歳 · 全性別 · 2026/09/25更新 · NCT07124000

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • The Kirklin Clinic of UAB Hospital, Birmingham
  • The University of Alabama at Birmingham, Birmingham
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

  • Investigative Site US058, Birmingham
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07522073

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

  • University of Alabama at Birmingham, Birmingham
被験者募集中
18歳以上 · 全性別 · 2026/09/10更新 · NCT05764720

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

  • University of Alabama at Birmingham Cancer Center, Birmingham
  • University of South Alabama Mitchell Cancer Institute, Mobile
被験者募集中観察研究
50歳〜75歳 · 全性別 · 2026/09/04更新 · NCT04239573

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • University of Alabama at Birmingham, Birmingham
  • University of South Alabama, Mobile
被験者募集中
18歳以上 · 全性別 · 2026/04/30更新 · NCT05297734

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

  • Ohio State University-Telemedicine, Birmingham
  • Ohio State University-Telemedicine, Mobile
  • Ohio State University Telemedicine, Montgomery
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/17更新 · NCT06906562

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Birmingham
  • Massive Bio SYNERGY-AI site, Mobile
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

  • University of Alabama Birmingham, Birmingham
被験者募集中観察研究
18歳以上 · 全性別 · 2025/02/25更新 · NCT02674100

ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。